MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurostimulation"

  • 2017 International Congress

    Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of DBS for Parkinson’s disease

    G. Deuschl, R. Jain, H. Scholtes, K. Steinke, A. Wang, M. Pötter-Nerger, L. Timmermann, J. Volkmann, A. Kühn, P. Eldridge, J. Fitzgerald, H. Mehdorn, J. Vesper (Kiel, Germany)

    Objective: To evaluate clinical outcomes in subjects implanted with a Directional Lead for use in the treatment of levodopa-responsive Parkinson’s disease (PD) as part of…
  • 2017 International Congress

    Spinal cord stimulation as therapeutic option in gait disorder in Parkinson disease.

    H. Cécile, D'H. Vincent, B.M. MALEK, p.-k. nathalie, t. Jean-Batiste, Z. MARC, B. Jean-Philippe (PARIS, France)

    Objective: We aim to study the effect of spinal cord stimulation over gait in parkinson disease without pain nor neuropathy. Background: Axial symptoms in the course…
  • 2017 International Congress

    Dopamine transporter imaging predicts motor response to dopaminergic therapy for patients with advanced Parkinson’s disease: Possible role in patient selection for subthalamic deep brain stimulation.

    A. Nakajima, Y. Shimo, S. Sekimoto, K. Kamagata, J. Takayuki, G. Oyama, A. Umemura, N. Hattori (Tokyo, Japan)

    Objective: To investigate the possible role of dopamine transporter (DAT) imaging in patient selection for subthalamic deep brain stimulation (STN-DBS) surgery, we retrospectively investigated the…
  • 2017 International Congress

    Safety of Unilateral and Bilateral DBS implants in ET: Preliminary results from Product Surveillance Registry

    M. Schiess, S. Falowski, G. Plotkin, S. Palfi, T. Witt, E. Cuny, T. Theys, K. Martinez, R. Plunkett, Y. Temel, G. Johnson, T. Weaver, J. Krauss, P. Konrad (Houston, TX, USA)

    Objective: To compare the safety of unilateral  (Uni) to bilateral (Blt) DBS implants in Essential Tremor (ET).  Background: DBS is an effective therapy in reducing…
  • 2016 International Congress

    Spinal cord stimulation improves freezing of gait in Parkinson’s disease in chronic implanted stn-dbs patients: A case report

    C.O. Souza, C.P. Souza, A.L. Pardini, D. Boari, L.A. Teixeira, E.R. Barbosa, E.T. Fonoff (Sao Paulo, Brazil)

    Objective: The aim of our study was to evaluate further the potential role of spinal cord stimulation (SCS) as a treatment for gait disturbances and…
  • 2016 International Congress

    The effect of anodal transcranial direct current stimulation (tDCS) on sequential motor skill learning in persons with Parkinson’s disease

    E. Kerckhofs, N. Deroost (Brussels, Belgium)

    Objective: To examine the potential effect of tDCS on the acquisition of implicit sequential motor skill learning in persons with PD (pwPD). Background: Due to…
  • 2016 International Congress

    Minimal impact of “interleaving” on neuromodulation device battery drain when interleave frequency is halved

    Y.M. Fernandez, D.L. Caputo, D.P. Schneider, S.F. Danish, R.J. Dipaola, E.L. Hargreaves (New Brunswick, NJ, USA)

    Objective: To contrast neurostimulator battery decay subsequent to the implementation of interleaving with that prior to interleaving. Background: Neurostimulators permit “interleaving”, which allows different same-lead…
  • 2016 International Congress

    Impulsive action tendencies in GPi DBS Parkinson’s patients

    D. Martinez-Ramirez, C.S. Little, J.P. Chapman, S. Carbunaru, J.C. Giugni, M.W. Vasquez, F. Chai, R. Walz, A. Sririam, K. Kanoff, S.A. Wylie, M.S. Okun (Gainesville, FL, USA)

    Objective: To test the effects of GPi DBS on susceptibility to impulsive action errors and the proficiency of reactive inhibitory control to counteract interference from…
  • 2016 International Congress

    Improvement of impulse control disorder in Parkinson’s disease patients treated with subthalamic nucleus stimulation

    E.J. Choi, J.K. Gu, D.G. Lee, S.M. Kim, J.K. Lee, C.S. Lee (Seoul, Korea)

    Objective: To find effects of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson's disease. Background: Parkinson's disease (PD) is a common…
  • 2016 International Congress

    Baseline physical activity may influence exercise-induced changes in cognitive function in Parkinson’s disease

    R. Chow, C.R.A. Silveira, B.N. Intzandt, E. Beck, Q.J. Almeida (Waterloo, ON, Canada)

    Objective: To determine how physical activity (PA) levels influence disease severity and cognitive function changes as a result of exercise in Parkinson's disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley